The University of Chicago Header Logo

Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen.

Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen. Am J Clin Pathol. 2024 Jan 04; 161(1):1-3.

View in: PubMed